Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Dixita I. Viswanath"'
Autor:
Hsuan‐Chen Liu, Simone Capuani, Andrew A. Badachhape, Nicola Di Trani, Daniel Davila Gonzalez, Robin S. Vander Pol, Dixita I. Viswanath, Shani Saunders, Nathanael Hernandez, Ketan B. Ghaghada, Shu‐Hsia Chen, Elizabeth Nance, Ananth V. Annapragada, Corrine Ying Xuan Chua, Alessandro Grattoni
Publikováno v:
Bioengineering & Translational Medicine, Vol 8, Iss 6, Pp n/a-n/a (2023)
Abstract Immune checkpoint inhibitors (ICI), pembrolizumab and atezolizumab, were recently approved for treatment‐refractory triple‐negative breast cancer (TNBC), where those with Programmed death‐ligand 1 (PD‐L1) positive early‐stage disea
Externí odkaz:
https://doaj.org/article/ae519761a40e482eaf80de02bca8ae93
Autor:
Nicola Di Trani, Corrine Ying Xuan Chua, Dixita I. Viswanath, Alessandro Grattoni, Ruogu Qi, Hsuan Chen Liu, Xuewu Liu
Publikováno v:
Nanomedicine
Hypertension is a chronic condition that requires lifelong therapeutic management. Strict adherence to drug administration timing improves efficacy, while poor adherence leads to safety concerns. In light of these challenges, we present a nanofluidic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0e9c796fd3311df7da47076481b19b42
https://europepmc.org/articles/PMC8475571/
https://europepmc.org/articles/PMC8475571/
Autor:
Dixita I. Viswanath, Alessandro Grattoni, Corrine Ying Xuan Chua, Hsuan-Chen Liu, David P. Huston
Publikováno v:
Biomaterials
Landmark successes in oncoimmunology have led to development of therapeutics boosting the host immune system to eradicate local and distant tumors with impactful tumor reduction in a subset of patients. However, current immunotherapy modalities often
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a1c59a463cdf30b0c4b9f20937b53eb
https://pubmed.ncbi.nlm.nih.gov/34902729
https://pubmed.ncbi.nlm.nih.gov/34902729
Autor:
Corrine Ying Xuan Chua, Alessandro Grattoni, Dixita I. Viswanath, Hsuan-Chen Liu, Robin Vander Pol
Publikováno v:
Late-breaking abstracts.
Background Pancreatic adenocarcinoma (PDAC) is associated with extremely poor prognosis and a 5-year survival rate of 10% and remains a lethal malignancy. Surgical resection and combination with chemoradiotherapy are the current standard-of-care opti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9556517345085ecd088ea6e34f78b547
https://doi.org/10.1136/jitc-2020-sitc2020.0757
https://doi.org/10.1136/jitc-2020-sitc2020.0757
Publikováno v:
Late-breaking abstracts.
Background Personalized therapeutic cancer vaccines aim to target and reprogram the host immune system to achieve cancer eradication in situ. Cancer vaccines deliver two main components: immunostimulants (iS) and tumor antigens to reduce tumor burden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d3e67d6bda4a287315772dd5bb2ec9c3
https://doi.org/10.1136/jitc-2020-sitc2020.0759
https://doi.org/10.1136/jitc-2020-sitc2020.0759
Autor:
Alessandro Grattoni, Jeremy Ho, Donald R. Erm, Dixita I. Viswanath, Xuewu Liu, Nicola Di Trani, Yitian Xu, Federica Pesaresi, Jesus Paez-Mayorga, Antonia Susnjar, Yu Wang, Edward Brian Butler, Licheng Zhang, Nathanael Hernandez, Hsuan Chen Liu, Shu Hsia Chen, Bin S. Teh, Sandra Demaria, Corrine Ying Xuan Chua
Publikováno v:
Int J Radiat Oncol Biol Phys
Purpose Mounting evidence demonstrates that combining radiation therapy (RT) with immunotherapy can reduce tumor burden in a subset of patients. However, conventional systemic delivery of immunotherapeutics is often associated with significant advers
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a721011c8173ec03cd1cbc5ed597ee8
https://europepmc.org/articles/PMC8547413/
https://europepmc.org/articles/PMC8547413/
Autor:
Dixita I. Viswanath, Athanasia E. Christakou, Emily M. Mace, Alexandre F. Carisey, Jordan S. Orange, Martin Wiklund, Hsiang-Ting Hsu, Björn Önfelt
Publikováno v:
The Journal of Cell Biology
Lytic granule convergence to the MTOC prepares NK cells for cytotoxic effector function. Hsu et al. demonstrate that convergence increases specificity in directed secretion, thereby preventing bystander killing.
Natural killer (NK) cell activati
Natural killer (NK) cell activati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c89c5861b7aaafe0c6b7a2143cbe41
https://doi.org/10.1083/jcb.201604136
https://doi.org/10.1083/jcb.201604136
Defining immunological mechanisms underlying NK cell biology is crucial for the treatment and prevention of immune deficiency and malignancy. The limited availability of human biological specimens presents a challenge to the study of human immunobiol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf3f78368f54e80aef9f1ee3a126cecb
https://europepmc.org/articles/PMC5010793/
https://europepmc.org/articles/PMC5010793/